Adenosine receptor ligands: differences with acute versus chronic treatment

Author： Jacobson K.A.   von Lubitz D.K.J.E.   Daly J.W.   Fredholm B.B.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.17, Iss.3, 1996-03, pp. : 108-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A 2A receptor agonist and antagonist

By Von Lubitz D.K.J.E.   Lin R.C.S.   Jacobson K.A.  

European Journal of Pharmacology, Vol. 287, Iss. 3, 1995-12 ,pp. : 295-302

Elsevier

Access to resources Recommend Favorite

Adenosine Receptor Ligands in Clinical Trials

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 10, 2010-07 ,pp. : 1036-1045

Bentham Science Publishers

Access to resources Recommend Favorite

Dopamine D1 receptor activation decreases GABA release through adenosine A1 receptor after chronic cocaine treatment

By Williams J.T.   Bonci A.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 196-196

Elsevier

Access to resources Recommend Favorite

Ligands for A2B Adenosine Receptor Subtype

By  

Current Medicinal Chemistry, Vol. 13, Iss. 28, 2006-12 ,pp. : 3467-3482

Bentham Science Publishers

Access to resources Recommend Favorite

Recent improvements in the field of A3 adenosine receptor ligands

By Baraldi Pier Giovanni   Fruttarolo Francesca   Tabrizi Mojgan Aghazadeh   Romagnoli Romeo   Preti Delia   Carriòn María Dora   Iaconinoto Antonietta   Borea Pier Andrea  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 11, 2005-11 ,pp. : 1507-1519

Informa Healthcare

Access to resources Recommend Favorite